Clinical Trials and Testing for COVID-19 Webinar
Doctors, scientists, and researchers across the world are searching for ways to effectively treat and prevent the spread of COVID-19. Recent headlines should serve as caution against promoting certain drugs as a one-size-fits-all cure before thorough research has been completed. Clinical trials offer a way to study potential treatments and monitor patient outcomes, but what are other benefits and risks? What else would you like to know about clinical trials and testing?
Engage with us by submitting a question on the registration form or during the webinar with live Q&A.
Moderator:
Mia Keeys, MA,
Director of Health Equity Policy and Advocacy at the American Medical Association
Panelists:
Dara Richardson-Heron, MD,
Chief Patient Officer at Pfizer, Inc.
Event Details
May 8, 2020 at 12:00pm EST - 1:00pm EST
Please submit questions to Keiko Purnell at kpurnell@nmqf.org. We also welcome suggestions for future webinar topics, as we plan to host more very soon!
